Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.6822
+0.0412 (6.43%)
At close: Oct 8, 2025, 4:00 PM EDT
0.6775
-0.0047 (-0.69%)
After-hours: Oct 8, 2025, 7:56 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.96 million as of October 8, 2025. Its market cap has decreased by -72.04% in one year.
Market Cap
2.96M
Enterprise Value
-646.47K
1-Year Change
-72.04%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.96M, a decrease of -98.57%. That is a compound annual growth rate of -73.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.78M | -71.51% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.91B |
| Johnson & Johnson | 453.36B |
| AbbVie | 406.71B |
| UnitedHealth Group | 325.13B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.80B |